Showing 8391-8400 of 10720 results for "".
Urticaria: Dr. Hawkes
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/urticaria-dr-hawkes/32690/Jason Hawkes, MD, talks about how to manage and approach chronic spontaneous urticaria patients, as well as novel therapeutic options, all of which he covered in "Urticaria Update 2025" at Maui Derm 2025.Eczematous Dermatitis: Dr. Zirwas
https://practicaldermatology.com/programs/practical-dermatology/eczematous-dermatitis-dr-zirwas/32689/Matthew Zirwas, MD, talks about the therapeutic strategies for non-atopic dermatitis—particularly hand dermatitis and facial dermatitis—that he covered during "Eczematous Dermatitis Update 2025: Contact, Hand, Head and Neck, Eyelid and More" at Maui Derm 2025.Combining Aesthetic Treatments: Dr. Chilukuri
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/combining-aesthetic-treatments-dr-chilukuri/32692/Suneel Chilukuri, MD, talks about some of the new regenerative options and combining them with devices and other therapies, as discussed in "What's My Treatment? How to Combine Dermal Filler, Neuromodulators, Laser/Light/RF Devices/Microneedling and Cosmeceuticals Symposium" at Maui Derm 2025.Psoriasis Update 2025: Dr. Gelfand
https://practicaldermatology.com/programs/practical-dermatology/psoriasis-update-2025-dr-gelfand/32672/Joel Gelfand, MD, MSCE, discusses highlights from the "Psoriasis Update 2025" panel at Maui Derm 2025, including the potential for combining TNF inhibitors with IL-23 inhibitors; home phototherapy; and the possibility of GLP-1 agonists lowering the severity of psoriatic disease.ASDS: Dr. Green on the Annual Meeting
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-dr-green-annual-meeting/29169/Lawrence Green, MD, FAAD, talks about the education and networking that make the American Society for Dermatologic Surgery Annual Meeting special.Expanded Indications for UltraClear Cold Ablative Fractional Fiber Laser
https://practicaldermatology.com/series/c-suite-chats/expanded-indications-ultraclear-cold-ablative-fractional-fiber-laser/26268/Shlomo Assa, President and Co-Founder of Acclaro Medical, discusses the versatility of the UltraClear Cold Ablative Fractional Fiber Laser, which recently received FDA clearance to treat benign pigmented lesions and vascular dyschromia.Current Unmet Needs in Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/current-unmet-needs-in-plaque-psoriasis/20098/Patrick Burnett, Chief Medical Officer of Arcutis Biotherapeutics, discusses new insights from a national survey on the psychosocial impact of plaque psoriasis and the current unmet need for topical therapies for plaque psoriasis. These data reinforce that psychosocial wellbeing can be just as imporMeaningful Innovation in Medical Dermatology at Arcutis Biotherapeutics
https://practicaldermatology.com/topics/psoriasis/meaningful-innovation-in-medical-dermatology-at-arcutis-biotherapeutics/20099/Frank Watanabe, President and CEO of Arcutis Biotherapeutics, shares what “meaningful innovation” means to Arcutis and how the company aims to create meaningful change for people living with chronic skin conditions.Liquid Rhinoplasty and Beyond: Injectable Pearls
https://practicaldermatology.com/videos/scientifically-speaking/liquid-rhinoplasty-and-beyond-injectable-pearls/20008/From the best approach to safe and effective liquid nose corrections to tips for enhancing outcomes and streamline operations, Michael Somenek, MD; Kay Durairaj, MD; Shino Bay Aguilera, DO; and Corey Hartman, MD share their best tips with host Joel L. Cohen, MD.Get Ready for JAK Inhibitors
https://practicaldermatology.com/topics/psoriasis/get-ready-for-jak-inhibitors/19928/JAK inhibitors are going to change the way we think about refractory disease, says Brett King, MD. He addresses the significant increase in study of these agents and the many potential uses for refractory diseases like alopecia, atopic dermatitis, vitiligo, psoriasis, and more.